Legal & General Group PLC Syndax Pharmaceuticals Inc Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Legal & General Group PLC holds 90,843 shares of SNDX stock, worth $1.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

90,843

Previous 90,843 -0.0%

Holding current value

$1.46 Million

Previous $1.75 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $116,778 - $161,587	6,513 Added 7.72%	90,843 $1.75 Million
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $273,868 - $346,192	14,552 Added 20.85%	84,330 $1.73 Million
Q1 2024 May 14, 2024	BUY	$19.71 - $24.57 $288,869 - $360,097	14,656 Added 26.59%	69,778 $1.66 Million
Q4 2023 Feb 15, 2024	BUY	$11.39 - $21.67 $56,323 - $107,158	4,945 Added 9.86%	55,122 $1.19 Million
Q3 2023 Nov 14, 2023	SELL	$14.52 - $21.77 $7,405 - $11,102	-510 Reduced 1.01%	50,177 $728,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $419,488 - $483,658	21,679 Added 74.73%	50,687 $1.06 Million
Q1 2023 May 15, 2023	BUY	$20.66 - $28.98 $160,073 - $224,537	7,748 Added 36.44%	29,008 $612,000
Q4 2022 Feb 14, 2023	BUY	$20.64 - $26.24 $42,188 - $53,634	2,044 Added 10.64%	21,260 $541,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $32,281 - $43,233	1,744 Added 9.98%	19,216 $462,000
Q2 2022 Aug 22, 2022	BUY	$13.64 - $19.48 $56,019 - $80,004	4,107 Added 30.73%	17,472 $336,000
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $12,940 - $19,314	872 Added 6.98%	13,365 $232,000
Q3 2021 Nov 15, 2021	BUY	$13.87 - $19.8 $103,331 - $147,510	7,450 Added 147.73%	12,493 $239,000
Q2 2021 Aug 12, 2021	SELL	$13.42 - $25.18 $6,602 - $12,388	-492 Reduced 8.89%	5,043 $87,000
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $27,107 - $34,573	1,406 Added 34.05%	5,535 $124,000
Q4 2020 Feb 12, 2021	BUY	$15.1 - $26.44 $12,185 - $21,337	807 Added 24.29%	4,129 $92,000
Q3 2020 Nov 13, 2020	SELL	$13.39 - $17.48 $15,050 - $19,647	-1,124 Reduced 25.28%	3,322 $49,000
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $6,249 - $14,665	699 Added 18.65%	4,446 $66,000
Q1 2020 May 14, 2020	SELL	$6.65 - $12.03 $3,677 - $6,652	-553 Reduced 12.86%	3,747 $41,000
Q4 2019 Feb 13, 2020	BUY	$5.43 - $9.22 $4,273 - $7,256	787 Added 22.4%	4,300 $38,000
Q2 2019 Aug 14, 2019	BUY	$4.9 - $9.31 $4,645 - $8,825	948 Added 36.96%	3,513 $33,000
Q2 2018 Aug 10, 2018	BUY	$6.93 - $14.63 $1,732 - $3,657	250 Added 10.8%	2,565 $18,000
Q4 2017 Feb 13, 2018	BUY	$7.8 - $12.94 $18,057 - $29,956	2,315	2,315 $20,000

Others Institutions Holding SNDX

# of Institutions

227

Shares Held

88.3M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $911M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Syndax Pharmaceuticals Inc Transaction History